FDA NDC Directory · JSON-LD · Markdown

BEOVU

NDC 0078-0827 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namebrolucizumab
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryBiologic License Application · App BLA761125
Dosage form / routeINJECTION, SOLUTION · INTRAVITREAL
Active ingredientsBROLUCIZUMAB (6 mg/.05mL)
Marketing started20191007
Package count2

External sources

Source: openFDA. Public-domain (CC0).